Business Wire

Biomax Informatics software licensed by global pharma company, Boehringer Ingelheim, to build a target discovery knowledge platform

Jaa

Biomax Informatics AG announces that their longtime client, Boehringer Ingelheim, has signed a multi-year license for the BioXM™ Knowledge Management Environment to support their global target discovery research. In addition, the company has extended their license for Biomax’s BioRS™ Integration and Retrieval System.

Boehringer Ingelheim is using the BioXM™ Knowledge Management Environment to build and maintain a target discovery knowledge platform that supports the company’s research on a global scale. The BioXM platform leverages Boehringer Ingelheim’s existing BioRS infrastructure to semantically integrate information from the company’s in-house systems and other proprietary and public data sources including pathways, compounds, sequences, genotypes, phenotypes, experimental data and text mining results. The BioXM platform allows all of the company’s external applications to access the data either directly or through application programming interfaces (APIs) and automates the updating of all integrated databases on a regular schedule.

“Boehringer Ingelheim has used the BioRS software for data integration for many years. Adding the BioXM software now lets them model their complete target discovery process in one easy-to-use, sustainable knowledge hub,” explained Dr. Kaj Albermann, who manages the Boehringer Ingelheim project at Biomax.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates and a total of around 50,000 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. www.boehringer-ingelheim.com

About Biomax

Biomax Informatics provides computational solutions for better decision making and knowledge management in the life sciences. They help customers generate value by integrating information from proprietary and public resources to enable a knowledge-based approach to developing innovative life science products. Biomax’s worldwide customer community includes clinics, companies and research organizations that are successful in drug discovery, diagnostics, fine chemicals, food and plant production. www.biomax.com

Biomax, BioRS and BioXM are registered trademarks of Biomax Informatics AG in Germany and other countries. Registered names, trademarks, etc., used in this document, even when not specifically marked as such, are not to be considered unprotected by law.

Contact information

Biomax Informatics AG
Dr. Philipp Krubasik, +49 89 895574-0
philipp.krubasik@biomax.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Axonics® Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares19.11.2018 19:30Tiedote

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions for the treatment of overactive bladder (“OAB”), fecal incontinence (“FI”), and urinary retention (“UR”), today announced that the underwriters of its initial public offering exercised in full their option to purchase an additional 1,200,000 shares of common stock from Axonics at the initial public offering price of $15.00 per share, less underwriting discounts and commissions. With this exercise, the total number of shares of common stock sold by Axonics in the offering increased to 9,200,000 shares, representing total gross proceeds of $138 million, before underwriting discounts and commissions and offering expenses. Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018. BofA Merrill Lynch a

Jefferies Appoints Fred Jallot Head of Fixed Income in Europe19.11.2018 17:52Tiedote

Jefferies today announced the appointment of Fred Jallot as Head of Fixed Income, Europe. He will be based in the firm’s London office starting January 2, 2019 and will report to Fred Orlan, Global Head of Fixed Income at Jefferies. Tim Cronin, who has also served as Head of Fixed Income, Europe, will relinquish this role and continue to serve as President of Jefferies International Limited, Jefferies’ London-based subsidiary. “We are very excited to have Fred Jallot join Jefferies’ leading global fixed income platform,” commented Mr. Orlan. “As a broadly experienced professional in global fixed income, his relationships and leadership will further enhance Jefferies’ growth in this market. This senior hire is an example of Jefferies’ emphasis on enhancing our firm’s European capabilities to serve our regional and global client base,” he added. Mr. Jallot was most recently Global Head of Credit and Asset-Backed Securities in Europe, the Middle East and Africa at Nomura, and previously s

From Niche to Normal – Cannabis Use Becoming More Accepted in the United States19.11.2018 17:47Tiedote

Growing numbers of consumers support the legalization of cannabis in some form and a majority believes it has a positive impact on the economy, according to the newly released 2018 Fall Cannabis Culture Poll, developed jointly by leading global communications agency BCW (Burson Cohn & Wolfe), PSB Research and Civilized, a premium media and lifestyle brand that embraces and highlights modern cannabis culture. A full 83 percent of the poll’s respondents (U.S. adults, cannabis consumers and non-consumers) say they support some form of legalization of cannabis. Sixty-three percent of non-consumers, and 95 percent of cannabis consumers, say legalization has had a positive economic effect on the states where use has been made legal. PSB Research, in partnership with BCW and Civilized, conducted online interviews between September 26 and October 4, 2018 with 1,200 U.S. adults aged 21 and older to explore views on cannabis and its usage and to determine general habits and behaviors of those wh

FRISS: Insurance Carriers Prioritize Fraud Detection and Prevention19.11.2018 16:00Tiedote

Insurance fraud is a global problem. In the U.S. alone, insurance carriers lost over $34 billion in 2017 on fraudulent insurance claims. It’s a global problem with a growing number of technological solutions. Big data analysis and large-scale collaboration are key to fighting insurance fraud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005015/en/ Insurance Fraud Report by FRISS (Graphic: Business Wire) The insurance industry is increasingly focused on preventing fraud through innovative systems, relying on the assistance of specialized vendors to help accomplish the task. The burden of detecting and reducing fraud, therefore, no longer lies with the individual insurer. The 2018 FRISS Insurance Fraud Survey reached over 150 industry professionals and shows a clear picture of the current awareness and challenges of fraud detection and mitigation. Key survey findings show: Increased focus on data quality The quality of

BOC Group´s ADOIT Receives the Highest Score in “Rearchitecting the Enterprise for Transformation” Use Case in Gartner’s 2018 Critical Capabilities for Enterprise Architecture Tools19.11.2018 15:04Tiedote

BOC Group, the leading global provider of Enterprise Management Solutions, is pleased to share its recognition in Gartner’s latest Critical Capabilities Report for Enterprise Architecture Tools*. ADOIT scores within the two highest across all three use cases, while scoring the highest out of eleven tools in “Rearchitecting the Enterprise for Transformation” use case. Christoph Moser, ADOIT product manager comments: "It is satisfying to be recognized by Gartner for our capabilities, which we are certain is due to our unique value proposition and holistic offering. We believe that our scores in this year's Gartner Critical Capabilities for Enterprise Architecture Tools report demonstrate our strength, innovation and continued investment in the agility, flexibility and versatility of our EA portfolio”. The Business Transformation Suite ADOIT supports customers worldwide in the digital transformation of their enterprise, facilitates alignment of their business and IT, and helps generate va

Chubu Centrair International Airport Has Been Ranked 5-Star Airport for Second Time19.11.2018 14:19Tiedote

Chubu Centrair International Airport has been ranked for the second consecutive year as a 5-star Airport*1, the world highest airport rank, in the Regional Airport*2 category. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005317/en/ In order to reply to the diversifying needs of the increasing international travellers, Chubu Centrair International Airport is aiming to become an easier to use and a more comfortable airport. In SKYTRAX’s*3 survey, which includes over 500 airport evaluation categories, Chubu Centrair International Airport has ranked specially high in “Airport staff service” and ”Airport cleanness” among other airports. In addition, Chubu Centrair International Airport has been also awarded in SKYTRAX’s “World Airport Awards”, an international airport rating based on client service, as “The World’s Best Regional Airport” (for 4th consecutive year since 2015) and ”Best Regional Airport-Asia” (for 8th conse

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme